Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

Icosapent Ethyl (Vascepa) significantly reduces revascularizations in statin patients based on data from the REDUCE-IT REVASC analyses, presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

News | Pharmaceuticals | May 17, 2020
May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy....
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020

The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration.

News | Stents | May 17, 2020
May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP)...
Cindy Grines Becomes SCAI President in 2020. #SCAI2020
News | SCAI | May 17, 2020
May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary...
The protocol chart for the LATIN STEMI telecardiology program.

The protocol chart for the LATIN STEMI telecardiology program.

News | Telecardiology | May 15, 2020
May 15, 2020 – A groundbreaking trial recently examined the viability of telemedicine for remote guidance of a...
An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

News | FFR Technologies | May 15, 2020
May 15, 2020 – A late-breaking study aimed to evaluate whether optical coherence tomography (OCT) can predict...
CMS now reimburses for outpatient center same-day percutenous coronary intervention but SCAI says quality guidelines need to be met. SCAI Expert Consensus Statement on Out of Hospital Cardiac Arrest. Catheterization and Cardiovascular Interventions
Feature | Cath Lab | May 15, 2020
May 15, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) issued a position statement on the...
New York City newspaper headlines from April 1, 2020, and masked police officers at a subway station in Manhattan clearly outline the issues facing the city's hospitals during the height of COVID-19 pandemic in New York. Photo by Mike Borchardt. How Cardiology Dealt With the COVID-19 Surge in New York City

New York City newspaper headlines from April 1, 2020, and masked police officers at a subway station in Manhattan clearly outline the issues facing the city's hospitals during the height of COVID-19 pandemic in New York. Photo by Mike Borchardt.

Feature | Coronavirus (COVID-19) | May 14, 2020 | Dave Fornell, Editor
Over the past three months COVID-19 has dominated nearly all healthcare news, so it is not surprising that the virus...
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography...
​​​​​​​American College of Cardiology, ACC, NCDR Chest Pain MI and CathPCI Registries Collect COVID-19 Data
News | Coronavirus (COVID-19) | May 11, 2020
May 11, 2020 — The American College of Cardiology (ACC) will begin collecting COVID-19 (SARS-CoV-2) data through the...
Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

Bilateral pulmonary embolisms seen on spectral CT. Photo courtesy of Siemens Healthineers.

Feature | Coronavirus (COVID-19) | May 04, 2020
May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of...
SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations. A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

A congenital atrial septal defect closed using a transcatheter occluder, visualized on 3-D TEE ultrasound.

News | Congenital Heart | May 04, 2020
May 4, 2020 – The Society for Cardiovascular Angiography and Interventions (SCAI) has released a position statement on...
Abiomed Adds ECMO Cardiopulmonary Support to its Portfolio with the purchase of Breethe. The Breethe ECMO system. Abiomed invested in Breethe in mid-2019. Breethe has applied for 510(k) clearance by the Food and Drug Administration (FDA).

The Breethe ECMO system. Abiomed invested in Breethe in mid-2019. Breethe has applied for 510(k) clearance by the Food and Drug Administration (FDA).

News | ECMO Systems | May 01, 2020
May 1, 2020 — Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal...
Videos | Coronavirus (COVID-19) | May 01, 2020
Thomas Maddox, M.D., MSc, FACC, the chair of the American College of Cardiology (ACC) Science and Quality Committee,...
LivaNova Modifies its ECMO Indications Beyond Six Hours to Address COVID-19. The FDA expanded the use indications for ECMO systems April 6 so tthey can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support.

The FDA expanded the use indications for ECMO systems April 6 so the systems can be used beyond six hours and for use in COVID-19 patients in need of circulatory and pulmonary support. Image shows an ECMO team at work at Tufts Medical Center in Boston in December 2019. Photo by Dave Fornell

News | Coronavirus (COVID-19) | April 23, 2020
April 23, 2020 – LivaNova PLC said the U.S. Food and Drug Administration (FDA) is now permitting the company to expand...
Videos | Coronavirus (COVID-19) | April 22, 2020
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and...